Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Histogen Inc. (CNAT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Histogen Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1383701.
Total stock buying since 2015: $58,189.
Total stock sales since 2015: $0.
Total stock option exercises since 2015: $167,150.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 20,000 | $22,799 | 0 | $0 | 0 | $0 |
| 2020 | 10,000 | $12,390 | 0 | $0 | 134,843 | $0 |
| 2018 | 0 | $0 | 0 | $0 | 72,121 | $74,430 |
| 2017 | 0 | $0 | 0 | $0 | 42,424 | $41,999 |
| 2016 | 0 | $0 | 0 | $0 | 59,595 | $50,721 |
| 2015 | 4,000 | $23,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-03 | 20,000 | $22,799 | 0 | $0 | 0 | $0 |
| 2020-12 | 10,000 | $12,390 | 0 | $0 | 0 | $0 |
| 2020-05 | 0 | $0 | 0 | $0 | 134,843 | $0 |
| 2018-05 | 0 | $0 | 0 | $0 | 60,000 | $59,400 |
| 2018-02 | 0 | $0 | 0 | $0 | 12,121 | $15,030 |
| 2017-01 | 0 | $0 | 0 | $0 | 42,424 | $41,999 |
| 2016-12 | 0 | $0 | 0 | $0 | 41,414 | $46,176 |
| 2016-10 | 0 | $0 | 0 | $0 | 18,181 | $4,545 |
| 2015-04 | 4,000 | $23,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-30 | Pascoe Richard W (President, CEO & Director) | Buy | 20,000 | 1.14 | 22,799 |
| 2020-12-03 | Pascoe Richard W (President, CEO & Director) | Buy | 10,000 | 1.24 | 12,390 |
| 2020-05-22 | Marshall Keith W (EVP, COO & CFO) | Option Ex | 38,500 | .00 | 0 |
| 2020-05-22 | Spada Alfred P. (EVP, R&D and CSO) | Option Ex | 31,343 | .00 | 0 |
| 2020-05-22 | Mento Steven J (Director) | Option Ex | 65,000 | .00 | 0 |
| 2018-05-04 | Mento Steven J (President, CEO & Director) | Option Ex | 60,000 | .99 | 59,400 |
| 2018-02-27 | Spada Alfred P. (EVP, R&D and CSO) | Option Ex | 12,121 | 1.24 | 15,030 |
| 2017-01-09 | Cashion Charles (SVP, Finance, CFO and Sec.) | Option Ex | 42,424 | .99 | 41,999 |
| 2016-12-20 | Mento Steven J (President, CEO & Director) | Option Ex | 41,414 | 1.11 | 46,176 |
| 2016-10-27 | Van Wart Harold (Director) | Option Ex | 18,181 | .25 | 4,545 |
| 2015-04-08 | Kisner Daniel L (Director) | Buy | 4,000 | 5.75 | 23,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CNAT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Histogen Inc. (symbol CNAT, CIK number 1383701) see the Securities and Exchange Commission (SEC) website.